Assessment of the functional state and Serum concentrations of pro- and anti-inflammatory mediators in individuals with grief and complicated grief.

Recruiting

• Conditions: F43; F33; Reaction to severe stress, and adjustment disorders; Recurrent depressive disorder

• Registration Number: DRKS00016160
• Lead Sponsor: Medizinische PsychologieNEMO

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-12-14
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Age 18-75 years
Relative of patients of the palliativ care unit
Willigness to participate in the study

Exclusion Criteria

Neurological disorders - substance abuse - psychiatric disorders - cardiovascular disorders - malignancy - pregnancy - acute/chronic infections - between 18-75 years

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Concentration changes of pro- and anti-inflammatory marker in serum and saliva will be determined using enzym-linked immuno Assay (ELISA). Saliva and Serum samples will be collected between 08.00-10.00 am within the study period (2 time points).

Secondary Outcome Measures

Name	Time	Method
Correlation with changes of the functional state of the grief participants.